Recent Quotes (30 days)

You have no recent quotes
chg | %

Vivione Biosciences Inc  

(Public, CVE:VBI)   Watch this stock  
Find more results for VBI
-0.035 (-17.50%)
Mar 27 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.17 - 0.17
52 week 0.14 - 0.44
Open 0.17
Vol / Avg. 3,000.00/6,634.00
Mkt cap 6.52M
P/E     -
Div/yield     -
EPS -0.06
Shares 39.62M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -3005.07% -1003.06%
Operating margin -3089.15% -725.09%
EBITD margin - -696.37%
Return on average assets -144.80% -174.75%
Return on average equity -621.33% -314.12%
CDP Score - -


34-161 Hoadley Road Pine Bluff Arsenal,Pine Bluff
United States - Map
+1-214-8865733 (Phone)
+1-509-5617287 (Fax)

Website links


Vivione Biosciences Inc. (Vivione), formerly Pacepartners Inc., is a technology and life sciences company. The Company has developed a diagnostic system called RAPID-B system, an integrated system of hardware, software and chemical reagents that tests for bacteria in key environments. RAPID-B system identifies bacteria and other pathogens in key food and water safety, clinical, industrial, as well as oil and gas environments. The Company is developing assays for the identification of pathogens, including Streptococcus pneumonia, Staphylococcus aureus, Acinetobacter baumannii, Klebsiella pneumonia, Psuedomonas aeruginosa and Escherichia coli. The Company is developing marketing and sales channels, production capabilities, as well as alliances with key suppliers and collaborators.

Officers and directors

Kevin Kuykendall Chief Executive Officer, Director
Chester J. Jachimiec Chief Financial Officer, Corporate Secretary
Age: 56
Philip A. Tuttle Director
Age: 70
Ian E. Gallie Independent Director
Age: 57
Lal Narang Independent Director
Age: 74